{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T09:29:30Z","timestamp":1758274170084,"version":"3.37.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T00:00:00Z","timestamp":1549497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00436-019-06224-x","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T19:46:40Z","timestamp":1549482400000},"page":"881-890","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The ABL kinase inhibitor imatinib causes phenotypic changes and lethality in adult Schistosoma japonicum"],"prefix":"10.1007","volume":"118","author":[{"given":"Xuesong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Haeberlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mudassar N.","family":"Mughal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junlong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph G.","family":"Grevelding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8381-6328","authenticated-orcid":false,"given":"Min","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,7]]},"reference":[{"issue":"7","key":"6224_CR1","doi-asserted-by":"publisher","first-page":"e478","DOI":"10.1371\/journal.pntd.0000478","volume":"3","author":"MH Abdulla","year":"2009","unstructured":"Abdulla MH, Ruelas DS, Wolff B, Snedecor J, Lim KC, Xu F, Renslo AR (2009) Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening. PLoS Negl Trop Dis 3(7):e478. \n                    https:\/\/doi.org\/10.1371\/journal.pntd.0000478","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"6224_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/med.2610030204","volume":"3","author":"P Andrews","year":"1983","unstructured":"Andrews P, Thomas H, Pohlke R, Seubert J (1983) Praziquantel. Med Res Rev 3(2):147\u2013200","journal-title":"Med Res Rev"},{"key":"6224_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3892\/ijmm.2017.3036","volume":"40","author":"F Ardito","year":"2017","unstructured":"Ardito F, Giuliani M, Perrone D, Troiano G, Lo Muzio L (2017) The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (review). In J Mol Med 40:271\u2013280. \n                    https:\/\/doi.org\/10.3892\/ijmm.2017.3036","journal-title":"In J Mol Med"},{"key":"6224_CR4","doi-asserted-by":"crossref","unstructured":"Beckmann S (2012) Protein kinases as potential targets for novel anti-schistosomal strategies. Curr Pharm Des 18(24):3579\u20133594","DOI":"10.2174\/138161212801327310"},{"issue":"5","key":"6224_CR5","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.ijpara.2010.01.007","volume":"40","author":"S Beckmann","year":"2010","unstructured":"Beckmann S, Grevelding CG (2010) Imatinib has a fatal impact on morphology, pairing stability and survival of adult Schistosoma mansoni in vitro. Int J Parasitol 40(5):521\u2013526. \n                    https:\/\/doi.org\/10.1016\/j.ijpara.2010.01.007","journal-title":"Int J Parasitol"},{"key":"6224_CR6","doi-asserted-by":"crossref","unstructured":"Beckmann S, Quack T, Burmeister C, Buro C, Long T, Dissous C, Grevelding CG (2010) Schistosoma mansoni: signal transduction processes during the development of the reproductive organs. Parasitol 137(03):497","DOI":"10.1017\/S0031182010000053"},{"issue":"49","key":"6224_CR7","doi-asserted-by":"publisher","first-page":"42325","DOI":"10.1074\/jbc.M110.210336","volume":"286","author":"S Beckmann","year":"2011","unstructured":"Beckmann S, Hahnel S, Cailliau K, Vanderstraete M, Browaeys E, Dissous C, Grevelding CG (2011) Characterization of the Src\/Abl hybrid kinase SmTK6 of Schistosoma mansoni. J Biol Chem 286(49):42325\u201342336. \n                    https:\/\/doi.org\/10.1074\/jbc.M110.210336","journal-title":"J Biol Chem"},{"issue":"3","key":"6224_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ijpddr.2014.07.005","volume":"4","author":"S Beckmann","year":"2014","unstructured":"Beckmann S, Long T, Scheld C, Geyer R, Caffrey C, Grevelding CG (2014) Serum albumin and \u03b1-1 acid glycoprotein impede the killing of Schistosoma mansoni by the tyrosine kinase inhibitor imatinib. Int J Parasitol Drugs Drug Resist 4(3):287\u2013295. \n                    https:\/\/doi.org\/10.1016\/j.ijpddr.2014.07.005","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"1","key":"6224_CR9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s40249-017-0286-2","volume":"6","author":"R Bergquist","year":"2017","unstructured":"Bergquist R, Utzinger J, Keiser J (2017) Controlling schistosomiasis with praziquantel: how much longer without a viable alternative? Infect Dis Poverty 6(1):74\u201383. \n                    https:\/\/doi.org\/10.1186\/s40249-017-0286-2","journal-title":"Infect Dis Poverty"},{"issue":"7253","key":"6224_CR10","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nature08160","volume":"460","author":"M Berriman","year":"2009","unstructured":"Berriman M, Haas BJ, LoVerde PT, Wilson RA, Dillon GP, Cerqueira GC, Mashiyama ST (2009) The genome of the blood fluke Schistosoma mansoni. Nature 460(7253):352\u2013358. \n                    https:\/\/doi.org\/10.1038\/nature08160","journal-title":"Nature"},{"key":"6224_CR11","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/S0959-8049(02)80600-1","volume":"5","author":"E Buchdunger","year":"2002","unstructured":"Buchdunger E, O\u2019Reilly T, Wood J (2002) Pharmacology of imatinib (STI571). Eur J Cancer Suppl 5:S28\u2013S36","journal-title":"Eur J Cancer Suppl"},{"issue":"6","key":"6224_CR12","doi-asserted-by":"publisher","first-page":"e2923","DOI":"10.1371\/journal.pntd.0002923","volume":"8","author":"C Buro","year":"2014","unstructured":"Buro C, Beckmann S, Oliveira KC, Dissous C, Cailliau K, Grevelding CG (2014) Imatinib treatment causes substantial transcriptional changes in adult Schistosoma mansoni in vitro exhibiting pleiotropic effects. PLoS Negl Trop Dis 8(6):e2923. \n                    https:\/\/doi.org\/10.1371\/journal.pntd.0002923","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"6224_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/00034983.1969.11686603","volume":"63","author":"AW Cheever","year":"1969","unstructured":"Cheever AW, Powers KG (1969) Schistosoma mansoni infection in rhesus monkeys: changes in egg production and egg distribution in prolonged infections in intact and splenectomized monkeys. Ann Trop Med Parasitol 63(1):83\u201393","journal-title":"Ann Trop Med Parasitol"},{"issue":"3","key":"6224_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.4269\/ajtmh.1994.50.281","volume":"50","author":"AW Cheever","year":"1994","unstructured":"Cheever AW, Macedonia JG, Mosimann JE, Cheever EA (1994) Kinetics of egg production and egg excretion by Schistosoma mansoni and S. japonicum in mice infected with a single pair of worms. Am J Trop Med Hyg 50(3):281\u2013295","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"6224_CR15","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","volume":"96","author":"MW Deininger","year":"2000","unstructured":"Deininger MW, Goldman JM, Melo JV (2000) The molecular biology of chronic myeloid leukemia. Blood 96(10):3343\u20133356","journal-title":"Blood"},{"issue":"12","key":"6224_CR16","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1002\/bies.20662","volume":"29","author":"C Dissous","year":"2007","unstructured":"Dissous C, Ahier A, Khayath N (2007) Protein tyrosine kinases as new potential targets against human schistosomiasis. BioEssays 29(12):1281\u20131288. \n                    https:\/\/doi.org\/10.1002\/bies.20662","journal-title":"BioEssays"},{"issue":"2","key":"6224_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1586\/14787210.4.2.199","volume":"4","author":"MJ Doenhoff","year":"2006","unstructured":"Doenhoff MJ, Pica-Mattoccia L (2006) Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance. Expert Rev Anti-Infect Ther 4(2):199\u2013210. \n                    https:\/\/doi.org\/10.1586\/14787210.4.2.199","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"6","key":"6224_CR18","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10787-011-0092-6","volume":"19","author":"DS El-Agamy","year":"2011","unstructured":"El-Agamy DS, Shebl AM, Said SA (2011) Prevention and treatment of Schistosoma mansoni-induced liver fibrosis in mice. Inflammopharmacology 19(6):307\u2013316. \n                    https:\/\/doi.org\/10.1007\/s10787-011-0092-6","journal-title":"Inflammopharmacology"},{"issue":"1","key":"6224_CR19","doi-asserted-by":"publisher","first-page":"Fso92","DOI":"10.4155\/fso.15.92","volume":"2","author":"D Goswami","year":"2016","unstructured":"Goswami D, Gurule S, Lahiry A, Anand A, Khuroo A, Monif T (2016) Clinical development of imatinib: an anticancer drug. Future Sci OA 2(1):Fso92. \n                    https:\/\/doi.org\/10.4155\/fso.15.92","journal-title":"Future Sci OA"},{"issue":"4","key":"6224_CR20","first-page":"180","volume":"22","author":"JK Grover","year":"2001","unstructured":"Grover JK, Vats V, Uppal G, Yadav S (2001) Anthelmintics: a review. Trop Gastroenterol 22(4):180\u2013189","journal-title":"Trop Gastroenterol"},{"key":"6224_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1146\/annurev-genom-082908-150036","volume":"10","author":"ZG Han","year":"2009","unstructured":"Han ZG, Brindley PJ, Wang SY, Chen Z (2009) Schistosoma genomics: new perspectives on schistosome biology and host-parasite interaction. Annu Rev Genomics Hum Genet 10:211\u2013240. \n                    https:\/\/doi.org\/10.1146\/annurev-genom-082908-150036","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"5","key":"6224_CR22","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00436-001-0588-x","volume":"88","author":"A Harder","year":"2002","unstructured":"Harder A (2002) Chemotherapeutic approaches to schistosomes: current knowledge and outlook. Parasitol Res 88(5):395\u2013397","journal-title":"Parasitol Res"},{"issue":"5","key":"6224_CR23","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.ijantimicag.2012.07.007","volume":"40","author":"S Hemer","year":"2012","unstructured":"Hemer S, Brehm K (2012) In vitro efficacy of the anticancer drug imatinib on Echinococcus multilocularis larvae. Int J Antimicrob Agents 40(5):458\u2013462. \n                    https:\/\/doi.org\/10.1016\/j.ijantimicag.2012.07.007","journal-title":"Int J Antimicrob Agents"},{"issue":"6","key":"6224_CR24","doi-asserted-by":"publisher","first-page":"821","DOI":"10.4155\/fmc.15.22","volume":"7","author":"J Hess","year":"2015","unstructured":"Hess J, Keiser J, Gasser G (2015) Toward organometallic antischistosomal drug candidates. Future Med Chem 7(6):821\u2013830. \n                    https:\/\/doi.org\/10.4155\/fmc.15.22","journal-title":"Future Med Chem"},{"key":"6224_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ceb.2007.02.010","volume":"19","author":"SR Hubbard","year":"2007","unstructured":"Hubbard SR, Miller WT (2007) Receptor tyrosine kinases: mechanisms of activation and signaling. Curr Opin Cell Biol 19:117\u2013123. \n                    https:\/\/doi.org\/10.1016\/j.ceb.2007.02.010","journal-title":"Curr Opin Cell Biol"},{"key":"6224_CR26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1146\/annurev.biochem.69.1.373","volume":"69","author":"SR Hubbard","year":"2000","unstructured":"Hubbard SR, Till JH (2000) Protein tyrosine kinase structure and function. Annu Rev Biochem 69:373\u2013398. \n                    https:\/\/doi.org\/10.1146\/annurev.biochem.69.1.373","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"6224_CR27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ccr.2004.09.001","volume":"6","author":"R Ishizawar","year":"2004","unstructured":"Ishizawar R, Parsons SJ (2004) c-Src and cooperating partners in human cancer. Cancer Cell 6(3):209\u2013214. \n                    https:\/\/doi.org\/10.1016\/j.ccr.2004.09.001","journal-title":"Cancer Cell"},{"issue":"3","key":"6224_CR28","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.exppara.2007.04.006","volume":"117","author":"J Knobloch","year":"2007","unstructured":"Knobloch J, Beckmann S, Burmeister C, Quack T, Grevelding CG (2007) Tyrosine kinase and cooperative TGFbeta signaling in the reproductive organs of Schistosoma mansoni. Exp Parasitol 117(3):318\u2013336. \n                    https:\/\/doi.org\/10.1016\/j.exppara.2007.04.006","journal-title":"Exp Parasitol"},{"issue":"1","key":"6224_CR29","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s13071-017-2293-3","volume":"10","author":"J Kovac","year":"2017","unstructured":"Kovac J, Vargas M, Keiser J (2017) In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium. Parasit Vectors 10(1):365\u2013366. \n                    https:\/\/doi.org\/10.1186\/s13071-017-2293-3","journal-title":"Parasit Vectors"},{"issue":"8","key":"6224_CR30","doi-asserted-by":"publisher","first-page":"4022","DOI":"10.1182\/blood-2007-10-116475","volume":"111","author":"RA Larson","year":"2008","unstructured":"Larson RA, Druker BJ, Guilhot F, O\u2019Brien SG, Riviere GJ, Krahnke T (2008) Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study. Blood 111(8):4022\u20134028. \n                    https:\/\/doi.org\/10.1182\/blood-2007-10-116475","journal-title":"Blood"},{"key":"6224_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-1-4939-0915-5_3","volume":"766","author":"FA Lewis","year":"2014","unstructured":"Lewis FA, Tucker MS (2014) Schistosomiasis. Adv Exp Med Biol 766:47\u201375. \n                    https:\/\/doi.org\/10.1007\/978-1-4939-0915-5_3","journal-title":"Adv Exp Med Biol"},{"issue":"Suppl 5","key":"6224_CR32","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1016\/S0959-8049(02)80599-8","volume":"38","author":"PW Manley","year":"2002","unstructured":"Manley PW, Cowan-Jacob SW, Buchdunger E, Fabbro D, Fendrich G (2002) Imatinib: a selective tyrosine kinase inhibitor. Eur J Cancer 38(Suppl 5):S19\u2013S27","journal-title":"Eur J Cancer"},{"issue":"1","key":"6224_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00436-004-1241-2","volume":"95","author":"RH Neves","year":"2005","unstructured":"Neves RH, de Lamare Biolchini C, Machado-Silva JR, Carvalho JJ (2005) A new description of the reproductive system of Schistosoma mansoni (Trematoda: Schistosomatidae) analyzed by confocal laser scanning microscopy. Parasitol Res 95(1):43\u201349. \n                    https:\/\/doi.org\/10.1007\/s00436-004-1241-2","journal-title":"Parasitol Res"},{"issue":"5","key":"6224_CR34","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/infdis\/jiv065","volume":"212","author":"EM O\u2019Connell","year":"2015","unstructured":"O\u2019Connell EM, Bennuru S, Steel C, Dolan MA, Nutman TB (2015) Targeting filarial Abl-like hinases: orally available, food and drug administration-approved tyrosine kinase inhibitors are microfilaricidal and macrofilaricidal. J Infect Dis 212(5):684\u2013693. \n                    https:\/\/doi.org\/10.1093\/infdis\/jiv065","journal-title":"J Infect Dis"},{"issue":"7","key":"6224_CR35","doi-asserted-by":"publisher","first-page":"e0005690","DOI":"10.1371\/journal.pntd.0005690","volume":"11","author":"EM O\u2019Connell","year":"2017","unstructured":"O\u2019Connell EM, Kamenyeva O, Lustigman S, Bell A, Nutman TB (2017) Defining the target and the effect of imatinib on the filarial c-Abl homologue. PLoS Negl Trop Dis 11(7):e0005690. \n                    https:\/\/doi.org\/10.1371\/journal.pntd.0005690","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"6224_CR36","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.bcmd.2015.05.007","volume":"55","author":"V Pathak","year":"2015","unstructured":"Pathak V, Colah R, Ghosh K (2015) Tyrosine kinase inhibitors: new class of antimalarials on the horizon? Blood Cells Mol Dis 55(2):119\u2013126. \n                    https:\/\/doi.org\/10.1016\/j.bcmd.2015.05.007","journal-title":"Blood Cells Mol Dis"},{"key":"6224_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0065-230X(02)85003-5","volume":"85","author":"AM Pendergast","year":"2002","unstructured":"Pendergast AM (2002) The Abl family kinases: mechanisms of regulation and signaling. Adv Cancer Res 85:51\u2013100","journal-title":"Adv Cancer Res"},{"issue":"4","key":"6224_CR38","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ijpara.2003.12.003","volume":"34","author":"L Pica-Mattoccia","year":"2004","unstructured":"Pica-Mattoccia L, Cioli D (2004) Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment. Int J Parasitol 34(4):527\u2013533. \n                    https:\/\/doi.org\/10.1016\/j.ijpara.2003.12.003","journal-title":"Int J Parasitol"},{"issue":"1","key":"6224_CR39","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.actatropica.2009.01.012","volume":"111","author":"L Pica-Mattoccia","year":"2009","unstructured":"Pica-Mattoccia L, Doenhoff MJ, Valle C, Basso A, Troiani AR (2009) Genetic analysis of decreased praziquantel sensitivity in a laboratory strain of Schistosoma mansoni. Acta Trop 111(1):82\u201385. \n                    https:\/\/doi.org\/10.1016\/j.actatropica.2009.01.012","journal-title":"Acta Trop"},{"issue":"1","key":"6224_CR40","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13045-018-0624-2","volume":"11","author":"F Rossari","year":"2018","unstructured":"Rossari F, Minutolo F, Orciuolo E (2018) Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy. J Hematol Oncol 11(1):84\u201397. \n                    https:\/\/doi.org\/10.1186\/s13045-018-0624-2","journal-title":"J Hematol Oncol"},{"issue":"31","key":"6224_CR41","doi-asserted-by":"publisher","first-page":"7936","DOI":"10.1002\/anie.201208390","volume":"52","author":"SA Thetiot-Laurent","year":"2013","unstructured":"Thetiot-Laurent SA, Boissier J, Robert A, Meunier B (2013) Schistosomiasis chemotherapy. Angew Chem Int Ed Eng 52(31):7936\u20137956. \n                    https:\/\/doi.org\/10.1002\/anie.201208390","journal-title":"Angew Chem Int Ed Eng"},{"issue":"s1","key":"6224_CR42","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1517\/17460441.2.S1.S63","volume":"2","author":"S Townson","year":"2007","unstructured":"Townson S, Ramirez B, Fakorede F, Mouries MA, Nwaka S (2007) Challenges in drug discovery for novel antifilarials. Expert Opin Drug Discovery 2(s1):S63\u2013S73. \n                    https:\/\/doi.org\/10.1517\/17460441.2.S1.S63","journal-title":"Expert Opin Drug Discovery"},{"key":"6224_CR43","first-page":"338","volume":"18","author":"J Wang","year":"1987","unstructured":"Wang J, Li Y, Zhou SL (1987) An observation of praziquantel effecting on the activity and survival of hepatic-portal-phase Schistosomulae of Schistosoma japonicum in vitro. Acta AcadMed Hebei 18:338\u2013342 [in Chinese]","journal-title":"Acta AcadMed Hebei"},{"issue":"13","key":"6224_CR44","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1017\/S0031182010001204","volume":"137","author":"W Wang","year":"2010","unstructured":"Wang W, Dai JR, Li HJ, Shen XH, Liang YS (2010) Is there reduced susceptibility to praziquantel in Schistosoma japonicum? Evidence from China. Parasitology 137(13):1905\u20131912. \n                    https:\/\/doi.org\/10.1017\/S0031182010001204","journal-title":"Parasitology"},{"issue":"2","key":"6224_CR45","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/BF00389901","volume":"52","author":"G Webbe","year":"1977","unstructured":"Webbe G, James C (1977) A comparison of the susceptibility to praziquantel of Schistosoma haematobium, S. japonicum, S. mansoni, S. intercalatum and S. mattheei in hamsters. Z Parasitenkd 52(2):169\u2013177","journal-title":"Z Parasitenkd"},{"issue":"1","key":"6224_CR46","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/s41598-017-18457-w","volume":"8","author":"JC Weeks","year":"2018","unstructured":"Weeks JC, Roberts WM, Leasure C, Suzuki BM, Robinson KJ (2018) Sertraline, paroxetine, and chlorpromazine are rapidly acting anthelmintic drugs capable of clinical repurposing. Sci Rep 8(1):975\u2013990. \n                    https:\/\/doi.org\/10.1038\/s41598-017-18457-w","journal-title":"Sci Rep"},{"issue":"49","key":"6224_CR47","first-page":"749","volume":"92","author":"WHO","year":"2017","unstructured":"WHO (2017) Schistosomiasis and soil-transmitted helminthiases: number of people treated in 2016. Wkly Epidemiol Rec 92(49):749\u2013760","journal-title":"Wkly Epidemiol Rec"},{"issue":"1","key":"6224_CR48","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12943-018-0775-3","volume":"17","author":"S Wu","year":"2018","unstructured":"Wu S, Fu L (2018) Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells. Mol Cancer 17(1):25\u201337. \n                    https:\/\/doi.org\/10.1186\/s12943-018-0775-3","journal-title":"Mol Cancer"},{"issue":"6","key":"6224_CR49","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1007\/s00436-011-2779-4","volume":"110","author":"SH Xiao","year":"2012","unstructured":"Xiao SH, Sun J, Xue J (2012) Confocal laser scanning microscopic observation on adult Schistosoma japonicum harbored in mice following treatment with single-dose mefloquine. Parasitol Res 110(6):2403\u20132411. \n                    https:\/\/doi.org\/10.1007\/s00436-011-2779-4","journal-title":"Parasitol Res"},{"issue":"8","key":"6224_CR50","doi-asserted-by":"publisher","first-page":"e3046","DOI":"10.1371\/journal.pntd.0003046","volume":"8","author":"LL Xu","year":"2014","unstructured":"Xu LL, Jiang B, Duan JH, Zhuang SF, Liu YC, Zhu SQ (2014) Efficacy and safety of praziquantel, tribendimidine and mebendazole in patients with co-infection of Clonorchis sinensis and other helminths. PLoS Negl Trop Dis 8(8):e3046. \n                    https:\/\/doi.org\/10.1371\/journal.pntd.0003046","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"6224_CR51","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/j.biotechadv.2013.09.003","volume":"31","author":"Q Ye","year":"2013","unstructured":"Ye Q, Dong HF, Grevelding CG, Hu M (2013) In vitro cultivation of Schistosoma japonicum-parasites and cells. Biotechnol Adv 31(8):1722\u20131737. \n                    https:\/\/doi.org\/10.1016\/j.biotechadv.2013.09.003","journal-title":"Biotechnol Adv"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00436-019-06224-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-019-06224-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-019-06224-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T19:07:46Z","timestamp":1581016066000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00436-019-06224-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,7]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["6224"],"URL":"https:\/\/doi.org\/10.1007\/s00436-019-06224-x","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"type":"print","value":"0932-0113"},{"type":"electronic","value":"1432-1955"}],"subject":[],"published":{"date-parts":[[2019,2,7]]},"assertion":[{"value":"17 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The conduct and procedures involving animal experimentation in this study were approved by the Scientific Ethics Committee of Huazhong Agricultural University (HZAUMO-2017-024) according to the regulations for the Administration of Affairs Concerning Experimental Animals of Hubei Province.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}